Connect Biopharma has appointed CBIZ CPAs P.C. as its new independent registered public accounting firm on December 17, 2024, following the dismissal of PricewaterhouseCoopers Zhong Tian LLP on December 10. The change was approved by the Audit Committee after careful consideration and evaluation.PwC China's reports for fiscal years 2022 and 2023 contained no adverse opinions or modifications. During these periods and through December 10, 2024, there were no disagreements between the Company and PwC China on accounting principles, financial statements, or auditing procedures.In a separate development, Zheng Wei, Ph.D. and Wubin Pan, Ph.D., MBA resigned from the Board of Directors on December 11, 2024, as part of the company's previously announced leadership transition to pursue new opportunities.

Connect Biopharma has appointed CBIZ CPAs P.C. as its new independent registered public accounting firm on December 17, 2024, following the dismissal of PricewaterhouseCoopers Zhong Tian LLP on December 10. The change was approved by the Audit Committee after careful consideration and evaluation.PwC China's reports for fiscal years 2022 and 2023 contained no adverse opinions or modifications. During these periods and through December 10, 2024, there were no disagreements between the Company and PwC China on accounting principles, financial statements, or auditing procedures.In a separate development, Zheng Wei, Ph.D. and Wubin Pan, Ph.D., MBA resigned from the Board of Directors on December 11, 2024, as part of the company's previously announced leadership transition to pursue new opportunities.